Gender disparity in pediatric diseases

D Del Principe1, M Marconi, P Matarrese

  • 1Istituto San Raffaele Sulmona, L'Aquila, Italy.

Current Molecular Medicine
|February 27, 2013
PubMed

Insights

Gender disparities in pediatric diseases are evident, with significant differences in morbidity and mortality for conditions like sepsis and cancer. Understanding these sex/gender differences is crucial for improving pediatric healthcare.

Area of Science:

  • Pediatric Medicine
  • Epidemiology
  • Genetics

Background:

  • Sex/gender differences are well-documented in adult complex diseases.
  • Pediatric diseases also exhibit gender disparities, though studies show varied results due to environmental and social factors.
  • Significant gender disproportion exists in childhood mortality and morbidity for severe conditions like sepsis, cancers, and immune disorders.

Purpose of the Study:

  • To review existing literature on sex/gender differences in pediatric morbidity and mortality.
  • To examine these differences across communicable and non-communicable diseases, including cancer.
  • To discuss potential underlying mechanisms, such as hormonal and epigenetic factors.

Main Methods:

  • Literature review of epidemiologic studies on pediatric sex/gender differences.
  • Analysis of data concerning communicable and non-communicable diseases in children.
  • Discussion of hormonal and epigenetic factors influencing observed disparities.

Main Results:

  • Gender disparities in pediatric diseases are present from early life.
  • Hormonal influences and differential gene expression in XX and XY cells contribute to these differences.
  • The extent of gender disparity varies significantly across different pediatric pathological conditions.

Conclusions:

  • Sex/gender differences in pediatric health are an early-occurring phenomenon.
  • Hormonal and epigenetic factors play a role in pediatric disease disparities.
  • Re-evaluating the gender issue in pediatric research can enhance diagnostic and therapeutic strategies.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Sex-linked Disorders01:43

Sex-linked Disorders

Like autosomes, sex chromosomes contain a variety of genes necessary for normal body function. When a mutation in one of these genes results in biological deficits, the disorder is considered sex-linked.